Cargando…
Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients
OBJECTIVES: This retrospective study examined how a pharmacist-involved education program in a multidisciplinary team (PEMT) for oral mucositis (OM) affected head-and-neck cancer (HNC) patients receiving concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: Total samples data of 53 patients du...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608342/ https://www.ncbi.nlm.nih.gov/pubmed/34807914 http://dx.doi.org/10.1371/journal.pone.0260026 |
_version_ | 1784602731748524032 |
---|---|
author | Yoshida, Kensuke Kodama, Yasumitsu Tanaka, Yusuke Pak, Kyongsun Soga, Marie Toyama, Akira Katsura, Kouji Takagi, Ritsuo |
author_facet | Yoshida, Kensuke Kodama, Yasumitsu Tanaka, Yusuke Pak, Kyongsun Soga, Marie Toyama, Akira Katsura, Kouji Takagi, Ritsuo |
author_sort | Yoshida, Kensuke |
collection | PubMed |
description | OBJECTIVES: This retrospective study examined how a pharmacist-involved education program in a multidisciplinary team (PEMT) for oral mucositis (OM) affected head-and-neck cancer (HNC) patients receiving concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: Total samples data of 53 patients during the stipulated timeframe were retrospectively collected from electronic medical records from February 2017 to January 2019. We compared the presence/absence of OM (OM: yes/no) between patients with and without PEMT (PEMT: yes/no) as the primary endpoint and OM severity as the secondary endpoint. The following information was surveyed: age, gender, weight loss, steroid or immunosuppressant use, hematological values (albumin, white blood cell count, blood platelets, and neutrophils), cancer grade, primary cancer site, type and use of mouthwash and moisturizer, opioid use (yes/no, days until the start of opioid use, and dose, switch to tape), and length of hospital day (LOD). The two groups were compared using Fisher’s exact test for qualitative data and the Mann-Whitney U test for quantitative data, and a significance level of p<0.05 was set. RESULTS: The group managed by PEMT had significantly lower weight loss and a significantly lower incidence of local anesthetic and opioid use and switch to tape compared with the group not managed by PEMT (p<0.05). The two groups showed no significant difference in OM (yes/no) or OM severity. The PEMT group had significantly shorter LOD at 57 (53–64) days compared with the non-PEMT group at 63.5 (57–68) days (p<0.05). CONCLUSIONS: Our results showed that PEMT did not improve OM (yes/no) or OM severity in HNC patients undergoing CCRT. However, the PEMT group had a lower incidence of grades 3 and 4 OM than the non-PEMT group, although not significantly. In addition, PEMT contributed to oral pain relief and the lowering of the risk for OM by reduction in weight loss. |
format | Online Article Text |
id | pubmed-8608342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-86083422021-11-23 Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients Yoshida, Kensuke Kodama, Yasumitsu Tanaka, Yusuke Pak, Kyongsun Soga, Marie Toyama, Akira Katsura, Kouji Takagi, Ritsuo PLoS One Research Article OBJECTIVES: This retrospective study examined how a pharmacist-involved education program in a multidisciplinary team (PEMT) for oral mucositis (OM) affected head-and-neck cancer (HNC) patients receiving concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: Total samples data of 53 patients during the stipulated timeframe were retrospectively collected from electronic medical records from February 2017 to January 2019. We compared the presence/absence of OM (OM: yes/no) between patients with and without PEMT (PEMT: yes/no) as the primary endpoint and OM severity as the secondary endpoint. The following information was surveyed: age, gender, weight loss, steroid or immunosuppressant use, hematological values (albumin, white blood cell count, blood platelets, and neutrophils), cancer grade, primary cancer site, type and use of mouthwash and moisturizer, opioid use (yes/no, days until the start of opioid use, and dose, switch to tape), and length of hospital day (LOD). The two groups were compared using Fisher’s exact test for qualitative data and the Mann-Whitney U test for quantitative data, and a significance level of p<0.05 was set. RESULTS: The group managed by PEMT had significantly lower weight loss and a significantly lower incidence of local anesthetic and opioid use and switch to tape compared with the group not managed by PEMT (p<0.05). The two groups showed no significant difference in OM (yes/no) or OM severity. The PEMT group had significantly shorter LOD at 57 (53–64) days compared with the non-PEMT group at 63.5 (57–68) days (p<0.05). CONCLUSIONS: Our results showed that PEMT did not improve OM (yes/no) or OM severity in HNC patients undergoing CCRT. However, the PEMT group had a lower incidence of grades 3 and 4 OM than the non-PEMT group, although not significantly. In addition, PEMT contributed to oral pain relief and the lowering of the risk for OM by reduction in weight loss. Public Library of Science 2021-11-22 /pmc/articles/PMC8608342/ /pubmed/34807914 http://dx.doi.org/10.1371/journal.pone.0260026 Text en © 2021 Yoshida et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yoshida, Kensuke Kodama, Yasumitsu Tanaka, Yusuke Pak, Kyongsun Soga, Marie Toyama, Akira Katsura, Kouji Takagi, Ritsuo Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients |
title | Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients |
title_full | Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients |
title_fullStr | Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients |
title_full_unstemmed | Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients |
title_short | Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients |
title_sort | pharmacist involved education program in a multidisciplinary team for oral mucositis: its impact in head-and-neck cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608342/ https://www.ncbi.nlm.nih.gov/pubmed/34807914 http://dx.doi.org/10.1371/journal.pone.0260026 |
work_keys_str_mv | AT yoshidakensuke pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients AT kodamayasumitsu pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients AT tanakayusuke pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients AT pakkyongsun pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients AT sogamarie pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients AT toyamaakira pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients AT katsurakouji pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients AT takagiritsuo pharmacistinvolvededucationprograminamultidisciplinaryteamfororalmucositisitsimpactinheadandneckcancerpatients |